首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Abstracts for a conference on trace elements in diet,nutrition, and health: essentiality and toxicity
Authors:L Y Shiu  C H Liang  Y S Huang  H M Sheu  K W Kuo
Institution:(1) Department of Biochemistry, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;(2) Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Chia Nan, Taiwan;(3) Department of Surgery, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;(4) Department of Dermatology, National Cheng Kung University, Tainan, Taiwan;(5) Research Center of Herbal Medicines, G&E Herbal Biotechnology, No. 26, Lane 31, Sec. 1, Huan Dong Rd., Tainan Science Park, SinShih, Tainan County, 74146, Taiwan
Abstract:Overexpression of HER2/neu is associated with drug resistance and poor outcome in breast cancer. Solamargine (SM), a glycoalkaloid purified from the herb Solanum incanum, exhibits HER2/neu gene modulation of HER2/neu high-expressing human breast cancer cell line ZR-75-1. SM downregulation of HER2/neu gene expression was determined by RT-PCR and Southern hybridization. Additionally, the membrane-bound HER2/neu receptor in highly HER2/neu-expressing breast cancer cells was determined by radioimmunoassay, immunocytochemistry, fluorescent immunocytochemistry, and flow cytometry. SM significantly decreased the number of HER2/neu receptors on the cell membrane. Methotrexate (MTX), 5-florouracil (5-Fu), and cisplatin (CDDP) are commonly used for breast carcinoma treatment in clinics; however, patients with HER2/neu overexpression exhibit resistance to these anticancer drugs. Notably, combination of MTX, 5-Fu, and CDDP with SM individually increased the susceptibility of breast cancer cells to these chemotherapeutic agents. Experimental results indicated that downregulation of HER2/neu by SM might be an effective strategy for enhancing drug susceptibility of breast cancer cells expressing high levels of HER2/neu.
Keywords:Solamargine  HER2/neu  Topoisomerase II  Methotrexate  5-Fluorouracil  Cisplatin
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号